Victory for Mayo in neurological disorder patent dispute
07-02-2019
Fed Circuit sides with district court in UCB win against generics
24-05-2018
14-01-2019
ADragan / iStockphoto.com
US-based Amerigen Pharmaceuticals has lost in its bid to prove that claims in a patent owned by biopharmaceutical company UCB were covered by a prior invention.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
UCB, Amerigen Pharmaceuticals, patent validity, inter partres review, Toviaz, US Patent and Trademark Office, Patent Trial and Appeal Board